Levels of anti-fructose-modified HSA antibodies correlate with disease status in diabetic subjects-Reference-Cited by-同舟云学术

Levels of anti-fructose-modified HSA antibodies correlate with disease status in diabetic subjects

Published:2016-07 Issue: Volume:88 Page:93-101
ISSN:0141-8130
Container-title:International Journal of Biological Macromolecules
language:en
Short-container-title:International Journal of Biological Macromolecules

Author:

Allarakha Shaziya,Dixit Kiran,Zaheer Mohammad Shoaib,Siddiqi Sheelu Shafiq,Moinuddin ,Ali Asif

Publisher

Elsevier BV

Subject

Molecular Biology,General Medicine,Biochemistry,Structural Biology

Reference32 articles.

1. D.E.R. Group. The diabetes control and complications trial/epidemiology of diabetes interventions and complications study at 30 years: summary and future directions;Gubitosi-Klug;Diabetes Care,2014

2. Monitoring of glycation: oxidative stress and inflammation in relation to the occurrence of vascular complications in patients with type 2 diabetes mellitus;Jakus;Physiol. Res.,2014

3. Glycation of nail proteins: from basic biochemical findings to a representative marker for diabetic glycation-associated target organ damage;Kishabongo;PLoS One,2015

4. Astaxanthin and corni fructus protect against diabetes-induced oxidative stress: inflammation, and advanced glycation end product in livers of streptozotocin-induced diabetic rats;Park;J. Med. Food,2015

5. Role of advanced glycosylation products in complications of diabetes;Cerami;Diabetes Care,1988

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multilayer Heterogeneous Membrane Biosensor Based on Multiphysical Field Coupling for Human Serum Albumin Detection;ACS Omega;2023-01-09

2. A Portable Device for Rapid Detection of Human Serum Albumin using an immunoglobulin-coating-based Magnetoelastic Biosensor;Biosensors and Bioelectronics;2019-09

3. Down-regulation of taurine-up-regulated gene 1 attenuates inflammation by sponging miR-9-5p via targeting NF-κB1/p50 in multiple sclerosis;Life Sciences;2019-09